NATALI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 11.807
EU - Europa 4.554
AS - Asia 1.722
AF - Africa 138
OC - Oceania 22
SA - Sud America 21
Continente sconosciuto - Info sul continente non disponibili 3
Totale 18.267
Nazione #
US - Stati Uniti d'America 11.508
IT - Italia 1.431
CN - Cina 944
SE - Svezia 924
BG - Bulgaria 669
GB - Regno Unito 329
CA - Canada 293
DE - Germania 268
TR - Turchia 253
VN - Vietnam 251
UA - Ucraina 209
FI - Finlandia 197
SM - San Marino 139
SG - Singapore 100
RU - Federazione Russa 91
IE - Irlanda 84
CI - Costa d'Avorio 74
CH - Svizzera 72
HK - Hong Kong 70
FR - Francia 45
SN - Senegal 39
IN - India 29
ES - Italia 22
AU - Australia 21
BE - Belgio 21
NG - Nigeria 17
IQ - Iraq 14
JP - Giappone 14
BR - Brasile 12
IR - Iran 11
NL - Olanda 10
PL - Polonia 10
AT - Austria 9
PT - Portogallo 7
AR - Argentina 5
CZ - Repubblica Ceca 5
KR - Corea 5
MX - Messico 5
RO - Romania 5
TW - Taiwan 5
IL - Israele 4
PH - Filippine 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
EG - Egitto 3
EU - Europa 3
MA - Marocco 3
PE - Perù 3
DK - Danimarca 2
ID - Indonesia 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AM - Armenia 1
BD - Bangladesh 1
CR - Costa Rica 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KW - Kuwait 1
LK - Sri Lanka 1
MM - Myanmar 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
TH - Thailandia 1
VE - Venezuela 1
Totale 18.267
Città #
Fairfield 1.657
Woodbridge 1.362
Houston 1.004
Ann Arbor 904
Chandler 845
Ashburn 796
Sofia 669
Seattle 647
Wilmington 550
Cambridge 527
Milan 498
New York 386
Beijing 378
Princeton 327
Ottawa 271
Jacksonville 268
Lawrence 260
Izmir 245
Medford 236
Serra 185
Nanjing 161
Des Moines 112
San Diego 93
Florence 92
London 83
Dearborn 80
Dong Ket 80
Nanchang 78
Abidjan 74
Bern 70
Hong Kong 67
Lancaster 66
Frankfurt am Main 42
Kunming 40
Dakar 39
Falls Church 39
Jüchen 39
Redwood City 39
Pisa 36
Hebei 35
Shenyang 35
Changsha 31
Rome 31
Tianjin 31
Los Angeles 28
Jiaxing 27
Ogden 26
Norwalk 25
Boulder 24
Washington 24
Orange 22
Hangzhou 21
Hefei 20
San Francisco 20
Boardman 18
Brussels 18
Lagos 17
Bremen 15
Menlo Park 15
Phoenix 15
Pietrasanta 15
Jinan 13
Toronto 13
Gavorrano 12
Guangzhou 11
Düsseldorf 10
Zhengzhou 10
Auburn Hills 9
Najaf 9
Warsaw 9
Lanzhou 8
Parma 8
Pune 8
Indiana 7
Vienna 7
Albenga 6
Changchun 6
Chicago 6
Detroit 6
Lucca 6
Marseille 6
Melbourne 6
Redmond 6
Shanghai 6
Tehran 6
Turin 6
Aberdeen 5
Costa Mesa 5
Fremont 5
Livorno 5
San Lazzaro di Savena 5
Sturt 5
Tokyo 5
Walnut 5
Barcelona 4
Council Bluffs 4
Edinburgh 4
Kilburn 4
Lappeenranta 4
Pomezia 4
Totale 14.122
Nome #
Hypertension: a metabolic disorder? 211
Prognostic Value Of 24-hour Ambulatory Blood Pressure And Heart Rate Patterns In Diabetes: A 20-year Longitudinal Analysis Of The Chronic Diabetes Complications And All-cause Mortality In Pisa From 1999 Onwards (CHAMP1ON) Study Cohort 211
Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance 160
Noninvasive measurement of forearm blood flow and oxygen consumption by near-infrared spectroscopy 155
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans - A quantitative study 148
Insulin resistance, adipose depots and gut: Interactions and pathological implications 143
Acute insulin administration does not affect plasma leptin levels in lean or obese subjects 134
Effects of insulin on the kidney and the cardiovascular system 131
Insulin resistance and hyperinsulinemia - No independent relation to left ventricular mass in humans 131
alpha-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population 131
Beta-cell function in obesity: effects of weight loss 130
Insulin: new roles for an ancient hormone 129
Diabetes and high blood pressure 123
Effect of acute hyperglycemia on insulin secretion in humans 120
Effects of short and prolonged mild intracellular nitric oxide manipulations on various aspects of insulin secretion in INS-1E β-cells. 120
Impact of empagliflozin on subclinical left ventricular dysfunctions and on the mechanisms involved in myocardial disease progression in type 2 diabetes: rationale and design of the EMPA-HEART trial. 119
Endothelial dysfunction in type 2 diabetes 117
Insulin sensitivity, vascular reactivity, and clamp-induced vasodilatation in essential hypertension 115
Influence of duration of obesity on the insulin resistance of obese non-diabetic patients 114
Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database 113
Hypertension, insulin resistance, and diabetes 112
Euglycemic clamp insulin sensitivity and longitudinal systolic blood pressure: role of sex 112
Determinants of postabsorptive endogenous glucose output in non-diabetic subjects 110
Independent stimulation of glucose metabolism and Na+-K+ exchange by insulin in the human forearm. 110
null 109
ANF IN PRIMARY ALDOSTERONISM - EFFECT OF DIETARY NA+ AND POSTURAL CHANGES AND RELATIONSHIP WITH ALDOSTERONE 108
Impact of lowering the criterion for impaired fasting glucose on identification of individuals with insulin resistance. The GISIR database. 108
Assessment of insulin-glucose uptake dose-response characteristics in the non-steady state 107
Hyperinsulinemia and autonomic nervous system dysfunction in obesity - Effects of weight loss 107
Coronary artery disease and stroke in type 2 diabetic patients: possible role of a raised central pulse pressure 107
null 107
Dietary sodium change in primary aldosteronism. Atrial natriuretic factor, hormonal, and vascular responses. Hypertension. 105
Autonomic and hemodynamic responses to insulin in lean and obese humans 105
Subclinical myopathy in a child with neutral lipid storage disease and mutations in the PNPLA2 gene 105
null 105
null 102
Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM 100
Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies 100
Measures of atherosclerotic burden are associated with clinically manifest cardiovascular disease in type 2 diabetes: A European cross-sectional study 99
Dose-response characteristics of insulin action on glucose metabolism: a non-steady-state approach 98
A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes 98
Relation of large artery remodelling and distensibility to insulin-resistance in patients with type 2 diabetes 97
Haemodynamic and metabolic phenotyping of hypertensive patients with and without heart failure by combining cardiopulmonary and echocardiographic stress test 96
Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortality 95
Muscle metabolism and exercise tolerance in subclinical hypothyroidism: A controlled trial of levothyroxine 93
Glucose uptake saturation explains glucose kinetics profiles measured by different tests 93
EFFECTS OF INSULIN ON HEMODYNAMICS AND METABOLISM IN HUMAN FOREARM 92
Use of Vascular Assessments and Novel Biomarkers to Predict Cardiovascular Events in Type 2 Diabetes: The SUMMIT VIP Study 92
Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on “The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function” 91
Statins, LDL Cholesterol Control, Cardiovascular Disease Prevention, and Atherosclerosis Progression: A Clinical Perspective 91
Effect of insulin on skeletal muscle metabolism in essential hypertension 90
Anti-inflammatory and Antioxidant Properties of HDLs Are Impaired in Type 2 Diabetes 90
Body Weight, Not Insulin Sensitivity or Secretion, May Predict Spontaneous Weight Changes in Nondiabetic and Prediabetic Subjects The RISC Study 90
Influence of endogenous NEFA on beta cell function in humans 90
Measurement of insulin-mediated glucose uptake: Direct comparison of the modified insulin suppression test and the euglycemic, hyperinsulinemic clamp 90
Intestinal glucose absorption is a key determinant of 1-hour postload plasma glucose levels in nondiabetic subjects 90
Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy RID F-2315-2010 89
Beta-cell function is associated with carotid intima-media thickness independently of insulin resistance in healthy individuals 89
null 89
Reciprocal association between insulin sensitivity and the haematocrit in man 89
Insulino Resistenza e Flusso Ematico: Studi con L'Adenosina in Pazienti con Ipertensione Essenziale 88
Carotid artery remodeling and compliance, insulin resistance, and lipid metabolism in type 2 diabetic patients. 88
null 88
null 88
LDL resistance to copper-induced oxidation: Effect of LDL lipid composition 87
Early metabolic markers of the development of dysglycaemia and type 2 diabetes and their physiological significance 87
Influence of apolipoproteins on the association between lipids and insulin sensitivity: a cross-sectional analysis of the RISC Study 86
Family history of diabetes predisposes to cardiovascular disease among patients with type 2 diabetes: What is the nature of the association? 85
Renovascular hypertension and insulin sensitivity 84
Insulin sensitivity and fasting insulin: association with indicators of cardiovascular disease in healthy subjects. The RISC Study 84
Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance 84
Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study 83
null 83
Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. 82
Association of fasting glucagon and proinsulin concentrations with insulin resistance 82
Insulin resistance of stress: Sites and mechanisms 82
A novel fasting blood test for insulin resistance and prediabetes 82
null 82
Insulin decreases circulating vitamin E levels in humans 81
Metabolic effects of combined antihypertensive treatment in patients with essential hypertension 81
Insulin resistance, insulin response, and obesity as indicators of metabolic risk 81
null 81
Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity 81
null 80
EFFECT OF INSULIN ON URIC-ACID EXCRETION IN HUMANS 79
Hypertension, insulin resistance, and the metabolic syndrome 79
Coronary artery disease and arterial hypertension: clinical, angiographic and follow-up data 79
Impaired insulin action on skeletal muscle metabolism in essential hypertension 79
A genome-wide association study of IVGTT-based measures of first-phase insulin secretion refines the underlying physiology of type 2 diabetes variants 79
Effect of insulin on skeletal muscle metabolism in essential hypertension 78
Metabolic syndrome: At the crossroads of cardiorenal risk 78
Is hyperglycemia a cardiovascular risk factor? 78
LDL resistance to oxidation: Effects of lipid phenotype, autologous HDL and alanine 78
The effect of lipoproteins on endothelial nitric oxide synthase is modulated by lipoperoxides 78
Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes: A nested, case–control study 78
null 78
Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance 76
Effect of vitamin C on forearm blood flow and glucose metabolism in essential hypertension 76
Defective Amplifying Pathway of β-cell Secretory Response to Glucose in Type 2 Diabetes: Integrated Modeling of in vitro and in vivo Evidence 76
null 76
Totale 9.960
Categoria #
all - tutte 53.679
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.679


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019963 0 0 0 0 0 0 0 0 0 0 512 451
2019/20203.772 422 270 128 227 335 396 463 438 431 262 304 96
2020/20212.026 169 125 163 107 234 94 91 244 147 202 128 322
2021/20222.890 43 145 115 224 534 392 63 171 132 52 150 869
2022/20232.759 400 317 178 201 303 359 23 219 482 32 208 37
2023/20242.098 270 273 334 182 375 421 82 71 46 42 2 0
Totale 18.793